Asthma medication

Article source Link, Article source Link,

Clients have used Provenance to identify market dynamics and brand growth opportunities not readily available with other data analysis tools. For example, Provenance was recently used with a leading pharmaceutical client to identify brand expansion opportunities in the asthma marketplace, and the specific prescriber and patient characteristics associated with those opportunities. The Provenance model provided the framework for the patient profiles used by sales representatives to promote the product.

PLYMOUTH MEETING, Pa., Oct. 23 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR) will present at the 2008 BIO InvestorForum being held October 29-31 at the Palace Hotel in San Francisco, CA. Jack Armstrong, president and chief executive officer, will present a company overview on Wednesday, October 29, 2008 at 2:15 p.m. (PST). About Genaera Genaera Corporation is developing trodusquemine (MSI-1436) for type 2 diabetes and obesity currently in phase 1 clinical testing and has a fully out-licensed partnership with MedImmune, Inc. that is in phase 2 clinical testing in asthma. For further information, please see our website at http://www.genaera.com

Blog Archives:
Refinish kitchen cabinet

Mens shirt

Allergic asthma symptoms

Suede shirt jacket

Sealing tile grout

Travertine tile flooring

49cc mopeds

Broan medicine cabinets

Brass cabinet knobs

Black slate tile

Cabinet hardware hinge

Toilet cabinet